Quote
The meeting will specifically address the continued occurrence of product recalls due to undeclared allergens and best practices for preventing the presence of undeclared allergens in FSIS-regulated products. Topics will focus on FSIS policy and enforcement regarding undeclared allergens, labeling compliance, best practices for prevention, and emerging issues.
Industry and interested individuals, organizations, and other stakeholders are invited to participate in the meeting and comment on these topics.